All cases N = 148 | Non Frailty N = 91 | Frailtya N = 57 | P values | |
---|---|---|---|---|
Age, years | 76.9 ± 7.4 | 75.1 ± 6.8 | 79.8 ± 7.5 | < 0.001 1) |
Male, n (%) | 63 (42.6) | 43 (47.3) | 20 (35.1) | 0.173 2) |
Body mass, kg | 57.4 ± 11.1 | 61.8 ± 9.6 | 49.1 ± 8.5 | < 0.001 1) |
BMI, kg/m2 | 23.2 ± 3.7 | 23.7 ± 3.5 | 22.3 ± 3.8 | 0.029 1) |
SBP, mmHg | 135.5 ± 19.0 | 138.5 ± 18.8 | 130.6 ± 18.4 | 0.013 1) |
DBP, mmHg | 72.4 ± 12.1 | 74.0 ± 12.2 | 69.9 ± 11.6 | 0.047 1) |
RBC, × 104/μL | 413 ± 58 | 424 ± 55 | 396 ± 59 | 0.005 1) |
Hemoglobin, g/dL | 12.7 ± 1.7 | 13.1 ± 1.7 | 12.1 ± 1.6 | 0.001 1) |
Albumin, g/dL | 3.95 ± 0.51 | 4.15 ± 0.32 | 3.63 ± 0.60 | < 0.001 1) |
AST, IU/L | 25.3 ± 10.7 | 26.7 ± 10.9 | 23.1 ± 10.3 | 0.047 1) |
ALT, IU/L | 16.5 [12.0–25.3] | 19.0 [13.0–27.0] | 15.0 [10.0–22.0] | 0.017 3) |
HbA1c, % | 6.92 ± 0.84 | 6.99 ± 0.79 | 6.80 ± 0.90 | 0.171 1) |
S-Creatinine, mg/dL | 0.70 [0.60–1.00] | 0.70 [0.60–0.90] | 0.80 [0.60–1.10] | 0.125 3) |
eGFR, mL/min/1.73 m2 | 59.5 [40.0–73.4] | 65.4 [52.3–74.4] | 54.9 [38.4–69.1] | 0.007 3) |
Uric acid, mg/dL | 5.16 ± 1.43 | 5.06 ± 1.33 | 5.33 ± 1.57 | 0.265 1) |
Triglycerides, mg/dL | 140 ± 77 | 139 ± 74 | 141 ± 82 | 0.911 1) |
LDL-C, mg/dL | 101 ± 31 | 102 ± 31 | 99 ± 31 | 0.623 1) |
HDL-C, mg/dL | 53.2 ± 14.3 | 56.0 ± 14.3 | 48.6 ± 13.4 | 0.002 1) |
Calcium, mg/dL | 9.35 ± 0.49 | 9.27 ± 0.36 | 9.48 ± 0.63 | 0.011 1) |
DHEA-S, μg/dL | 57.5 [39.0–89.0] | 66.0 [44.5–106.0] | 48.0 [33.0–68.0] | 0.002 3) |
Cortisol, μg/dL | 9.50 ± 2.79 | 9.09 ± 2.77 | 10.16 ± 2.71 | 0.022 1) |
Ratio Cortisol/ DHEA-S | 0.16 [0.10–0.25] | 0.13 [0.09–0.22] | 0.20 [0.14–0.34] | < 0.001 3) |
Anti-HT drug use, n (%) | 87 (58.8) | 51 (56.0) | 36 (63.2) | 0.493 2) |
Anti-DL drug use, n (%) | 72 (48.6) | 44 (48.4) | 28 (49.1) | 0.999 2) |